218 related articles for article (PubMed ID: 25967717)
1. A study of RUNX3, E-cadherin and β-catenin in CagA-positive Helicobacter pylori associated chronic gastritis in Saudi patients.
Wagih HM; El-Ageery SM; Alghaithy AA
Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1416-29. PubMed ID: 25967717
[TBL] [Abstract][Full Text] [Related]
2. RUNX3 Methylation, Loss of RUNX3 Expression and Clinicopathologic Findings according to Helicobacter pylori CagA in Gastric Carcinoma.
Na YJ; Shim KN; Joo YH; Kim SE; Jung HK; Jung SA; Cho MS
Korean J Gastroenterol; 2015 Aug; 66(2):75-84. PubMed ID: 26289240
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells.
Murata-Kamiya N; Kurashima Y; Teishikata Y; Yamahashi Y; Saito Y; Higashi H; Aburatani H; Akiyama T; Peek RM; Azuma T; Hatakeyama M
Oncogene; 2007 Jul; 26(32):4617-26. PubMed ID: 17237808
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the relationship between dietary factors, CagA-positive Helicobacter pylori infection, and RUNX3 promoter hypermethylation in gastric cancer tissue.
Zhang YW; Eom SY; Yim DH; Song YJ; Yun HY; Park JS; Youn SJ; Kim BS; Kim YD; Kim H
World J Gastroenterol; 2013 Mar; 19(11):1778-87. PubMed ID: 23555166
[TBL] [Abstract][Full Text] [Related]
5. Expression of the E-cadherin/β-catenin/tcf-4 pathway in gastric diseases with relation to Helicobacter pylori infection: clinical and pathological implications.
Yu XW; Xu Q; Xu Y; Gong YH; Yuan Y
Asian Pac J Cancer Prev; 2014; 15(1):215-20. PubMed ID: 24528029
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori CagA status, mucosal oxidative damage and gastritis phenotype: a potential pathway to cancer?
Farinati F; Cardin R; Russo VM; Busatto G; Franco M; Rugge M
Helicobacter; 2003 Jun; 8(3):227-34. PubMed ID: 12752735
[TBL] [Abstract][Full Text] [Related]
7. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status.
Sozzi M; Valentini M; Figura N; De Paoli P; Tedeschi RM; Gloghini A; Serraino D; Poletti M; Carbone A
Am J Gastroenterol; 1998 Mar; 93(3):375-9. PubMed ID: 9517643
[TBL] [Abstract][Full Text] [Related]
8. Study of p53 immunostaining in the gastric epithelium of cagA-positive and cagA-negative Helicobacter pylori gastritis.
Teh M; Tan KB; Seet BL; Yeoh KG
Cancer; 2002 Aug; 95(3):499-505. PubMed ID: 12209741
[TBL] [Abstract][Full Text] [Related]
9. Gastric epithelial cell proliferation and cagA status in Helicobacter pylori gastritis at different gastric sites.
Cabral MM; Oliveira CA; Mendes CM; Guerra J; Queiroz DM; Rocha GA; Rocha AM; Nogueira AM
Scand J Gastroenterol; 2007 May; 42(5):545-54. PubMed ID: 17454874
[TBL] [Abstract][Full Text] [Related]
10. Downregulated Expression of E-cadherin and TP53 in Patients with Gastric Diseases: the Involvement of H. pylori Infection and Its Virulence Markers.
Ferraz MA; Zabaglia LM; Pereira WN; Orcini WA; de Labio RW; Caleman Neto A; Wisnieski F; Calcagno DQ; Santos LC; Assumpção PP; Burbano RR; Artigiani R; Smith Mde A; Payão SL; Rasmussen LT
J Gastrointest Cancer; 2016 Mar; 47(1):20-6. PubMed ID: 26585943
[TBL] [Abstract][Full Text] [Related]
11. An inverse relationship between the expression of the gastric tumor suppressor RUNX3 and infection with Helicobacter pylori in gastric epithelial dysplasia.
Chung WC; Jung SH; Joo KR; Kim MJ; Youn GJ; Kim Y; Lee JS; Lee H; Jung JH; Lee YK
Gut Liver; 2013 Nov; 7(6):688-95. PubMed ID: 24312710
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of the gastric tumor suppressor RUNX3 following H. pylori infection results in its localization to the cytoplasm.
Cinghu S; Goh YM; Oh BC; Lee YS; Lee OJ; Devaraj H; Bae SC
J Cell Physiol; 2012 Mar; 227(3):1071-80. PubMed ID: 21567391
[TBL] [Abstract][Full Text] [Related]
13. Expression of cytokeratins in Helicobacter pylori-associated chronic gastritis of adult patients infected with cagA+ strains: an immunohistochemical study.
Todorovic V; Sokic-Milutinovic A; Drndarevic N; Micev M; Mitrovic O; Nikolic I; Wex T; Milosavljevic T; Malfertheiner P
World J Gastroenterol; 2006 Mar; 12(12):1865-73. PubMed ID: 16609992
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome-mediated degradation.
Tsang YH; Lamb A; Romero-Gallo J; Huang B; Ito K; Peek RM; Ito Y; Chen LF
Oncogene; 2010 Oct; 29(41):5643-50. PubMed ID: 20676134
[TBL] [Abstract][Full Text] [Related]
15. Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis.
Shimoyama T; Everett SM; Dixon MF; Axon AT; Crabtree JE
J Clin Pathol; 1998 Oct; 51(10):765-70. PubMed ID: 10023340
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori cagA and iceA genotypes status and risk of peptic ulcer in Saudi patients.
Momenah AM; Tayeb MT
Saudi Med J; 2007 Mar; 28(3):382-5. PubMed ID: 17334464
[TBL] [Abstract][Full Text] [Related]
17. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression.
Lu XX; Yu JL; Ying LS; Han J; Wang S; Yu QM; Wang XB; Fang XH; Ling ZQ
Cancer; 2012 Nov; 118(22):5507-17. PubMed ID: 22576578
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori CagA status associated with gastric cancer incidence rate variability in Costa Rican regions.
Con SA; Valerín AL; Takeuchi H; Con-Wong R; Con-Chin VG; Con-Chin GR; Yagi-Chaves SN; Mena F; Brenes Pino F; Echandi G; Kobayashi M; Monge-Izaguirre M; Nishioka M; Morimoto N; Sugiura T; Araki K
J Gastroenterol; 2006 Jul; 41(7):632-7. PubMed ID: 16932999
[TBL] [Abstract][Full Text] [Related]
19. CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer.
Kudo M; Gutierrez O; El-Zimaity HM; Cardona H; Nurgalieva ZZ; Wu J; Graham DY
J Clin Pathol; 2005 Mar; 58(3):259-62. PubMed ID: 15735156
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of beta-catenin signal by Helicobacter pylori CagA requires the CagA-multimerization sequence.
Kurashima Y; Murata-Kamiya N; Kikuchi K; Higashi H; Azuma T; Kondo S; Hatakeyama M
Int J Cancer; 2008 Feb; 122(4):823-31. PubMed ID: 17960618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
